Madrigal Pharmaceuticals, Inc..
MDGL.US | Research and experimental development on natural sciences and engineering
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapeutics for non-alcoholic steatohepatitis (NASH), a serious liver disease. Their primary focus is the development and potential commercialization of resmetirom, a thyroid hormone recept...Show More
Better Health for All
0
No relevant evidence was found in the provided articles to assess Madrigal Pharmaceuticals, Inc. against the 'Better Health for All' ethical value. All articles either resulted in 404 errors or explicitly stated they contained no data specific to MDGL.US or this value.
1
Fair Money & Economic Opportunity
0
Madrigal Pharmaceuticals is a biopharmaceutical company focused on research, development, and clinical trials for therapeutics. Its core business does not involve lending, insuring, moving, or storing money, which are the activities evaluated under the 'Fair Money & Economic Opportunity' value. Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcomes, financial literacy initiatives, debt burden ratio, geographic inclusion, and product simplicity, are not applicable to its business model.
1
While the company offers patient assistance programs for drug access,
2
these are distinct from community finance or profit-sharing with underserved communities in the financial sense.
Fair Pay & Worker Respect
0
No evidence available to assess Madrigal Pharmaceuticals, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Madrigal Pharmaceuticals, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, quantitative evidence was found across the provided articles to assess Madrigal Pharmaceuticals, Inc. against any of the 'Honest & Fair Business' KPIs. While an SEC settlement was mentioned, no specific financial value or terms were detailed, preventing scoring for regulatory fines.
1
Kind to Animals
0
No evidence available to assess Madrigal Pharmaceuticals, Inc. on Kind to Animals.
No War, No Weapons
0
Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing therapeutics for liver disease. The company is explicitly stated as not involved in military contracting, controversial weapons, or small arms.
1
Its core business does not involve defense or arms-related activities, dual-use technology, or military-focused AI.
2
Therefore, there is no defense business for the board to oversee, no ethical red lines related to weapons are needed, and no peace technology investment ratio is applicable in the context of military technology.
Planet-Friendly Business
-30
Madrigal Pharmaceuticals has a waste management target of 75% recycling.
1
The company reported 97% compliance with EPA environmental guidelines and no specific regulatory actions, violations, fines, or compliance issues.
2
It conducted 14 environmental impact studies in 2024, with an average assessment duration of 6.2 months.
3
Respect for Cultures & Communities
0
No evidence available to assess Madrigal Pharmaceuticals, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Madrigal Pharmaceuticals, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
-20
Madrigal Pharmaceuticals has no mentioned regulatory actions, violations, fines, or compliance issues related to waste disposal.
1
However, no data is provided regarding waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certifications, material efficiency, packaging-to-product ratios, waste reduction targets, supplier waste requirements, or customer waste education.
2